Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Intrexon

Intrexon
1998 FOUNDED
PUBLIC STATUS
901-1000 EMPLOYEES
XON STOCK SYMBOL
25 INVESTMENTS
$5.53 SHARE PRICE (As of Monday Closing)
Description

Intrexon is a biotechnology company that develops synthetic biology solutions. The company designs, builds, and regulates gene programs. Its technologies are broadly applicable across a wide range of diverse end markets. Intrexon's business model is to commercialize its technologies through exclusive channel collaborations with collaborators that have specific industry expertise, development resources, and sales and marketing capabilities, in order to bring new and improved products and processes to market. The company's collaborators provide compensation through technology access fees, royalties, milestones, and reimbursement of certain costs.

Website
Formerly Known As
Genomatix
Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Biotechnology
Stock Exchange
NAS
Primary Office
  • 20374 Seneca Meadows Parkway
  • Germantown, MD 20876
  • United States

+1 (301) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Intrexon’s full profile, request a free trial.

Intrexon Stock Performance

52 wk Range Market Cap Prev. Close EPS Average Volume Shares
$3.95 - $10.89 $896M $5.64 -$3.68 995K 162M

Intrexon Financials Summary

In Thousands,
USD
TTM
30-Jun-2019
FY 2018
31-Dec-2018
FY 2017
31-Dec-2017
FY 2016
31-Dec-2016
Enterprise Value 1,331,242 997,692 1,309,894 2,661,767
Revenue 134,954 160,574 230,981 190,926
EBITDA (483,337) (513,676) (117,429) (178,908)
Net Income (497,264) (509,336) (117,018) (186,612)
Total Assets 655,188 716,177 846,851 949,068
Total Debt 256,904 212,260 8,270 8,768
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Intrexon Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Intrexon‘s full profile, request access.

Request full access to PitchBook

Intrexon Competitors (22)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Codexis Formerly VC-backed Redwood City, CA 000 00000 000000 - 000 00000
000000 Venture Capital-Backed Seattle, WA 00 000.00 00000000000 000.00
000000 00000000 Venture Capital-Backed Boston, MA 000 00000 00000000000 00000
000000000 Corporation Bagsvaerd, Denmark 0000 00000000
000000000 00000000 Formerly PE-Backed Oklahoma City, OK 000 0000 000000&0 0000
To view this company’s complete list of competitors, request access »

Intrexon Investments & Acquisitions (25)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
000000000 09-Nov-2017 0000 0000000000 00.00 Pharmaceuticals
000000 16-Jun-2017 000000000000000000 00000 Pharmaceuticals 000000 0000 00.0
000000 00000000000 27-Sep-2016 000000000 Biotechnology
00000000 000 00000 04-Apr-2016 00000 0000000 Drug Discovery 000000 000000 00
Enviroflight 01-Feb-2016 Merger/Acquisition 00.00 Other Consumer Non-Durables 00000 0000
To view this company’s complete investment and acquisition history, request access »

Intrexon Exits (1)

Company Name Exit Date Exit Type Exit Size Status Buyers
00000000 000000000 27-Mar-2015 0000 0000 Completed
  • 7 buyers
To view this company’s complete exits history, request access »

Intrexon Subsidiaries (8)

Company Name Industry Location Founded
Exemplar Genetics Biotechnology Sioux Center, IA 2008
0000000 0000000000 Biotechnology Budapest, Hungary 0000
00000000 Biotechnology San Diego, CA 0000
000000 Animal Husbandry Cedar Park, TX 0000
000000 Other Agriculture Abingdon, United Kingdom 0000
To view this company’s complete subsidiary history, request access »

Intrexon Executive Team (31)

Name Title Board
Seat
Contact
Info
Randal Kirk JD Chief Executive Officer & Chairman
John McLean President, Intrexon Crop Protection
Rick Sterling Chief Financial Officer & Chief Accounting Officer
Thomas Bostick Ph.D Chief Operating Officer
Donald Lehr JD Chief Legal Officer

18 Former Executives

You’re viewing 5 of 31 executives. Get the full list »

Intrexon Board Members (10)

Name Representing Role Since Contact
Info
Cesar Alvarez JD Self Board Member 000 0000
Dean Mitchell Self Board Member 000 0000
Fred Hassan Self Board Member 000 0000
James Turley Self Board Member 000 0000
Jeffrey Kindler JD Self Board Member 000 0000

2 Former Board Members

You’re viewing 5 of 10 board members. Get the full list »